CRISPR Therapeutics AG - Common Shares (CRSP)
$44.40
0.11 (0.25%)
CRSP Stock Quote Delayed 30 Minutes
7 Stock Bargains Worth a Look After the Most Recent Pullback
Value investors may choose to buy stocks that are out of favor and from among beaten up stock bargains in a variety of sectors.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
3.50B
PE Ratio
-10.21
EPS
-4.35
Volume (Avg. Vol.)
1.24M
Day's Range
$43.97 - $46.00
52-Week Range
$36.52 - $90.62
Dividend & Yield
N/A (N/A)
CRSP Stock Predictions, Articles, and CRISPR Therapeutics AG - Common Shares News
CRSP Stock: The Cancer Study News Sending Crispr Therapeutics Lower Today
Crispr Therapeutics (CRSP) stock is falling on Wednesday following the release of new results from a Phase 1 clinical trial.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're at the halfway point of the trading week and that has us checking in on the biggest pre-market stock movers for Wednesday!
3 Cathie Wood Stocks To Trade for Bulls as Well as Bears
As the saying goes, bulls and bears make money. And today in these three Cathie Wood stocks both camps should be ready for action
Gene Editing Stocks: The Trial News Lifting NTLA, CRSP and EDIT Stocks Today
Today, gene editing stocks are getting a big boost after an intriguing data release by Editas for the company's new SLEEK technology.
Updated Clinical and Financial Data Make the Case for CRISPR Therapeutics
Looking for a terrific value in the biotechnology space? It doesn't get much better than CRSP stock, which just entered a buy zone.
Gene Editing Stocks: Why EDIT, NTLA, CRSP Stocks Are Climbing Today
Today, investors in gene editing stocks are seeing a lot of green as earnings were announced along with business updates from key players.
CRSP Stock: The Good News Goosing CRISPR Therapeutics Shares Today
Shares of CRSP stock are rising on Friday after CRISPR Therapeutics provided a positive business update regarding its leading drug candidate.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We've got one more day of trading before the weekend so let's start it off with the biggest pre-market stock market movers for Friday.
Crispr Therapeutics Represents the Best of Emerging Biotechnology
CRSP stock may end up being a pioneer, or it may fizzle. The timeline until we know is typical of biotech stocks.
Crispr Therapeutics Has Bullish DNA
Crispr Therapeutics isn't without risks, but that shouldn't dissuade investors from a CRSP stock collar purchase for core positioning.
Can CRISPR Therapeutics Stock Investors Steer Clear of Ethical Concerns?
While the technologies that undergird CRSP stock is nothing short of mind-blowing, you should be aware of the ethical risks.
Investing in CRISPR Stocks: Ultimate Genetic Editing Guide
The biotech space is on the verge of hypergrowth, thanks to a scientific breakthrough in genetic editing. This is your ultimate guide to understanding and profiting from CRISPR stocks.
The Top 7 Gene-Editing Stocks to Buy for the Biggest Scientific Breakthrough of the Century
Doudna's breakthrough in CRISPR has since ushered in a new era of genetic engineering, making these the best gene-editing stocks to buy.
Gene Editing Stocks: Why EDIT, CRSP, NTLA Stocks Continue to Soar
Today, gene editing stocks are soaring amid increasingly bullish sentiment in this sector following strong results from Intellia.
What Will the Stock Market Do Today? 3 Big Stories to Watch.
So what will the stock market do today? All eyes are on gene-editing stocks like NTLA and on recovering crypto prices.
Gene Editing Stocks: The Big News Lifting EDIT, BNGO, CRSP and NTLA Stocks
Gene editing stocks are getting a boost on Monday morning after Intellia Therapeutics said it was successful using CRISPR gene-editing therapy directed inside the body to an internal organ.
